Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening
This study looking at mortality reduction, years of life saved and cost -effectiveness for women who underwent an annual CA-125 and on a rising result underwent a subsequent transvaginal ultrasound . Results showed a moderate decrease in mortality (13%). The tests were found to meet cost effective guidelines.
The Role of Secondary Cytoreductive Surgery in Patients with Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers: A Comparative Effectiveness Analysis
This comparative study showed reported the cytoreductive surgery used to treat recurrent Ovarian cancer may increase overall survival.
Every Day is a Blessing!